SEI Investments’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

SEI Investments’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-41,890	Closed	-$4.27M	–	2733
2023 Q2	$4.27M	Buy	41,890 +29,529	+239%	+$2.79M	0.01%	1263
2023 Q1	$1.12M	Sell	12,361 -9,065	-42%	-$532K	﹤0.01%	1831
2022 Q4	$814K	Buy	+21,426	New	+$737K	﹤0.01%	1835
2021 Q4	–	Sell	-7,241	Closed	-$746K	–	2685
2021 Q3	$746K	Sell	7,241 -95	-1%	-$11.1K	﹤0.01%	1888
2021 Q2	$1.07M	Sell	7,336 -241	-3%	-$27.2K	﹤0.01%	1790
2021 Q1	$835K	Sell	7,577 -331	-4%	-$38.6K	﹤0.01%	1829
2020 Q4	$963K	Buy	7,908 +3,194	+68%	+$420K	﹤0.01%	1704
2020 Q3	$457K	Sell	4,714 -204	-4%	-$25.5K	﹤0.01%	1920
2020 Q2	$767K	Sell	4,918 -784	-14%	-$119K	﹤0.01%	1671
2020 Q1	$821K	Buy	5,702 +960	+20%	+$185K	﹤0.01%	1541
2019 Q4	$971K	Buy	+4,742	New	+$865K	﹤0.01%	1650
2019 Q3	–	Sell	-5,275	Closed	-$494K	–	2441
2019 Q2	$494K	Sell	5,275 -2,192	-29%	-$189K	﹤0.01%	1887
2019 Q1	$635K	Sell	7,467 -1,198	-14%	-$99.5K	﹤0.01%	1765
2018 Q4	$486K	Buy	+8,665	New	+$529K	﹤0.01%	1760

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SEI Investments's RETA Position: Q3 2023 in Review

SEI Investments sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 41,890 shares — an estimated $4.27M sold.

SEI Investments first reported a position in RETA in Q4 2018 and held it in 14 quarters. The position peaked at $4.27M in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

SEI Investments reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
SEI Investments sold 41,890 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $4.27M.
SEI Investments first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2018 and held it in 14 quarters.
SEI Investments's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $4.27M in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on SEI Investments's 13F filing for Q3 2023, filed 14 Nov 2023.